Insilico
-
Technology & Infrastructure · Models & LLMs AI-Designed Drug Shows Signs of Lowering Biological Age in Early Clinical Study
Insider Brief An artificial intelligence-designed drug for a deadly lung disease produced protein changes associated with lower biological age, offering early evidence that AI-discovered medicines could be evaluated for effects beyond the diseases they… -
Technology & Infrastructure · Models & LLMs Insilico Medicine Convenes an Open Consortium For Benchmark Quality in AI-Driven Drug Discovery
-
Business & Markets AI Insider’s The Week in Review: OpenAI for Government, G7 Leaders, Pope Address AI, Amazon to Cut Jobs Amid AI Adoption, Plus Companies Raise Funds for Drug Discovery, Automation Across Industries
-
Business & Markets · Enterprise
AI-designed TNIK Inhibitors Could Treat a Range of Aging-Related Diseases, From Fibrosis to Alzheimer’s.
The AI economy, every weekday morning
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.